BMRN
Biomarin Pharmaceutical IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$10.45B
P/E Ratio
38.91
EPS
$1.39
Beta
0.23
52W High
$66.28
52W Low
$49.26
50-Day MA
$54.46
200-Day MA
$55.91
Dividend Yield
—
Profit Margin
8.29%
Forward P/E
10.86
PEG Ratio
0.47
About Biomarin Pharmaceutical Inc
BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California.
Fundamentals
| Revenue (TTM) | $3.24B |
| Gross Profit (TTM) | $1.66B |
| EBITDA | $631.29M |
| Operating Margin | 18.00% |
| Return on Equity | 4.48% |
| Return on Assets | 4.49% |
| Revenue/Share (TTM) | $16.87 |
| Book Value | $32.14 |
| Price-to-Book | 1.68 |
| Price-to-Sales (TTM) | 3.22 |
| EV/Revenue | 2.983 |
| EV/EBITDA | 20.05 |
| Quarterly Earnings Growth (YoY) | -43.10% |
| Quarterly Revenue Growth (YoY) | 2.80% |
| Shares Outstanding | $193.28M |
| Float | $192.17M |
| % Insiders | 0.30% |
| % Institutions | 102.75% |
Historical Volatility
HV 10-Day
50.71%
HV 20-Day
41.13%
HV 30-Day
34.68%
HV 60-Day
31.99%
HV Rank
86.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($87.85 target)
5
Strong Buy14
Buy5
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026